InvestorsHub Logo
Followers 129
Posts 3809
Boards Moderated 0
Alias Born 07/12/2003

Re: None

Monday, 09/11/2023 8:38:45 PM

Monday, September 11, 2023 8:38:45 PM

Post# of 198716
Virogentics, Inc. Provides Update on African Project, European Medicine Agency Application and Clinical Trials for Application for Type 2 Diabetes
ACCESSWIRE - Fri Aug 4, 4:30AM CDT

https://www.theglobeandmail.com/investing/markets/stocks/ENZC/pressreleases/19097626/virogentics-inc-provides-update-on-african-project-european-medicine-agency-application-and-clinical-trials-for-application-for-type-2-diabetes/

Barry Kostiner, CEO of Sagaliam, commented, "Enzolytics has assembled an impressive team in Bulgaria, and is benefitting from the European regulators who have supported the accelerated development of therapeutics for the benefit of patients desperately in need of improved efficacy at lower costs. EMA's dedication to fostering a healthy and well-regulated pharmaceutical landscape is truly commendable and deserving of praise. I am looking forward to my meetings with our team in Sofia next month, and contributing to the advancement of the financial, implementation and marketing plan."